DTC

The US Food and Drug Administration (“FDA”) Office of Prescription Drug Promotion (“OPDP”) recently issued an enforcement letter…

The FDA’s Office of Prescription Drug Promotion (OPDP) issued its second untitled letter of the year to California drugmaker Vivus…

The US Food and Drug Administration (“FDA”) recently published a notice in the Federal Register seeking to find out more about how…

On June 14, 2019, several pharmaceutical companies filed suit against the Department of Health and Human Services (“HHS”), seeking…

As reported by Regulatory Focus, a new review of studies of direct-to-consumer (DTC) prescription drug advertising identifies…

On May 8, 2019, the Department of Health and Human Services (“HHS”) announced a final rule that will require direct-to-consumer…

According to research funded by the FDA and published last month, participants in a study on direct-to-consumer (DTC) advertising…

On December 17, 2018, the Pharmaceutical Research and Manufacturers of America (PhRMA) submitted comments in response to the…

In October 2018, the United States Food and Drug Administration (FDA) released a draft guidance on how to present efficacy and…

On Monday, October 15, 2018, member companies of the Pharmaceutical Research and Manufacturers of America (PhRMA) announced a…